CA2318374C - Human suppressor trna oligonucleotides and methods of use for same - Google Patents
Human suppressor trna oligonucleotides and methods of use for same Download PDFInfo
- Publication number
- CA2318374C CA2318374C CA2318374A CA2318374A CA2318374C CA 2318374 C CA2318374 C CA 2318374C CA 2318374 A CA2318374 A CA 2318374A CA 2318374 A CA2318374 A CA 2318374A CA 2318374 C CA2318374 C CA 2318374C
- Authority
- CA
- Canada
- Prior art keywords
- trna
- vector
- oligonucleotide
- region
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B10/00—Transmission systems employing electromagnetic waves other than radio-waves, e.g. infrared, visible or ultraviolet light, or employing corpuscular radiation, e.g. quantum communication
- H04B10/25—Arrangements specific to fibre transmission
- H04B10/2589—Bidirectional transmission
- H04B10/25891—Transmission components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Electromagnetism (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Signal Processing (AREA)
- Computer Networks & Wireless Communication (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7141698P | 1998-01-14 | 1998-01-14 | |
| US60/071,416 | 1998-01-14 | ||
| PCT/US1999/000717 WO1999036519A1 (en) | 1998-01-14 | 1999-01-13 | HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2318374A1 CA2318374A1 (en) | 1999-07-22 |
| CA2318374C true CA2318374C (en) | 2012-09-04 |
Family
ID=22101183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2318374A Expired - Fee Related CA2318374C (en) | 1998-01-14 | 1999-01-13 | Human suppressor trna oligonucleotides and methods of use for same |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6309830B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1045902B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002508959A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE299179T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2225199A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2318374C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69926052T2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999036519A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002508959A (ja) * | 1998-01-14 | 2002-03-26 | ヒューマン ジーン セラピー リサーチ インスティテュート | ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法 |
| KR20010079671A (ko) * | 1998-08-20 | 2001-08-22 | 스티븐 에이. 서윈. 엠.디. | 재조합 유전자 생성물을 생성시키는 동안 세포독성을조절하는 억제 tRNA의 용도 |
| WO2003033521A1 (en) * | 2001-10-16 | 2003-04-24 | Massachusetts Institute Of Technology | Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides. |
| US20050261210A1 (en) * | 2004-02-19 | 2005-11-24 | Bhatnagar Rajiv S | Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders |
| WO2005086768A2 (en) * | 2004-03-11 | 2005-09-22 | Albert Einstein College Of Medicine Of Yeshiva University | Enhanced production of functional proteins from defective genes |
| WO2008064304A2 (en) * | 2006-11-22 | 2008-05-29 | Trana Discovery, Inc. | Compositions and methods for the identification of inhibitors of protein synthesis |
| ATE553764T1 (de) * | 2007-09-14 | 2012-05-15 | Trana Discovery | Zusammensetzungen und verfahren zur identifizierung von inhibitoren einer retrovirusinfektion |
| CA2776044A1 (en) * | 2008-09-29 | 2010-04-01 | Trana Discovery, Inc. | Screening methods for identifying specific staphylococcus aureus inhibitors |
| CN107177592B (zh) * | 2016-03-10 | 2021-03-30 | 北京大学 | 抑制性tRNA通读提前终止密码子疾病中的截短蛋白 |
| CN110612353A (zh) * | 2017-03-03 | 2019-12-24 | 加利福尼亚大学董事会 | 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向 |
| MX2020004587A (es) * | 2017-11-02 | 2021-04-12 | Univ Iowa Res Found | Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt. |
| WO2020069194A1 (en) * | 2018-09-26 | 2020-04-02 | Case Western Reserve University | Methods and compositions for treating a premature stop codon-mediated disorder |
| JP2022528696A (ja) * | 2019-04-11 | 2022-06-15 | アークタラス テラピュウティクス、インク | アンチコドンループを延長した合成転移rna |
| LU101182B1 (en) * | 2019-04-11 | 2020-10-12 | Univ Hamburg | Synthetic transfer RNA with extended anticodon loop |
| JP7712270B2 (ja) | 2019-11-01 | 2025-07-23 | テバード バイオサイエンシズ インコーポレイテッド | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| US11827880B2 (en) | 2019-12-02 | 2023-11-28 | Shape Therapeutics Inc. | Therapeutic editing |
| BR112022020780A2 (pt) | 2020-04-14 | 2022-11-29 | Flagship Pioneering Innovations Vi Llc | Composições de trem e usos das mesmas |
| US20230203510A1 (en) * | 2020-05-29 | 2023-06-29 | Flagship Pioneering Innovations Vi, Llc | Trem compositions and methods relating thereto |
| WO2022125531A1 (en) * | 2020-12-07 | 2022-06-16 | President And Fellows Of Harvard College | Methods for making and using genomically recoded cells |
| AU2023212951A1 (en) * | 2022-01-25 | 2024-08-29 | Hc Bioscience, Inc. | Universal suppressor trnas and uses thereof |
| USD1118947S1 (en) * | 2024-05-29 | 2026-03-17 | Shock Doctor, Inc. | Knee brace |
| USD1121161S1 (en) * | 2024-05-29 | 2026-03-31 | Shock Doctor, Inc. | Knee brace |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4687737A (en) | 1982-11-12 | 1987-08-18 | Massachusetts Institute Of Technology | Mammalian suppressor genes |
| US4970155A (en) * | 1983-03-07 | 1990-11-13 | Abbott Laboratories | HSV helper virus independent vector |
| US6111095A (en) * | 1995-06-07 | 2000-08-29 | Merck & Co., Inc. | Capped synthetic RNA, analogs, and aptamers |
| JP2002508959A (ja) * | 1998-01-14 | 2002-03-26 | ヒューマン ジーン セラピー リサーチ インスティテュート | ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法 |
-
1999
- 1999-01-13 JP JP2000540221A patent/JP2002508959A/ja active Pending
- 1999-01-13 EP EP99902219A patent/EP1045902B1/en not_active Expired - Lifetime
- 1999-01-13 AT AT99902219T patent/ATE299179T1/de not_active IP Right Cessation
- 1999-01-13 CA CA2318374A patent/CA2318374C/en not_active Expired - Fee Related
- 1999-01-13 US US09/229,212 patent/US6309830B1/en not_active Expired - Lifetime
- 1999-01-13 WO PCT/US1999/000717 patent/WO1999036519A1/en not_active Ceased
- 1999-01-13 DE DE69926052T patent/DE69926052T2/de not_active Expired - Lifetime
- 1999-01-13 AU AU22251/99A patent/AU2225199A/en not_active Abandoned
-
2001
- 2001-10-30 US US10/022,127 patent/US7029665B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2318374A1 (en) | 1999-07-22 |
| US7029665B2 (en) | 2006-04-18 |
| DE69926052T2 (de) | 2006-04-27 |
| EP1045902A1 (en) | 2000-10-25 |
| US20020156042A1 (en) | 2002-10-24 |
| JP2002508959A (ja) | 2002-03-26 |
| DE69926052D1 (de) | 2005-08-11 |
| WO1999036519A1 (en) | 1999-07-22 |
| EP1045902B1 (en) | 2005-07-06 |
| AU2225199A (en) | 1999-08-02 |
| ATE299179T1 (de) | 2005-07-15 |
| US6309830B1 (en) | 2001-10-30 |
| HK1033955A1 (en) | 2001-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1045902B1 (en) | HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME | |
| EP0454781B1 (en) | Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof | |
| US5861290A (en) | Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders | |
| US5830727A (en) | Herpes simplex virus amplicon mini-vector gene transfer system | |
| AU2016373365B2 (en) | Transposon system, kit comprising the same, and uses thereof | |
| EP3822346A1 (en) | Use of engineered packaging cell lines for producing recombinant virus particles | |
| EP2406379A1 (en) | Compositions and methods for the delivery of biologically active rnas | |
| JP6608284B2 (ja) | 癌の治療に使用されるrnaトランススプライシング分子(rtm) | |
| Panchal et al. | Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA | |
| US20140170709A1 (en) | Vector for gene therapy | |
| EP3359676B1 (en) | Transposon system, kit comprising the same, and uses thereof | |
| JP2025148442A (ja) | Rnaによる単純ヘルペス ウイルスi型およびその他の関連するヒトヘルペス ウイルスの根絶 | |
| HK1033955B (en) | Human suppressor trna oligonucleotides and methods of use for same | |
| Semple-Rowland et al. | Expression characteristics of dual-promoter lentiviral vectors targeting retinal photoreceptors and Müller cells | |
| US20230220361A1 (en) | Crispr-cas9 mediated disruption of alcam gene inhibits adhesion and trans-endothelial migration of myeloid cells | |
| EP0796338B1 (fr) | Lignees cellulaires d'encapsidation pour la transcomplementation de vecteurs retroviraux defectifs | |
| EP1045920A1 (en) | Nucleotide expression systems with reduced immunogenicity for use in gene therapy | |
| US20230279398A1 (en) | Treating human t-cell leukemia virus by gene editing | |
| WO2026003067A1 (en) | Transcription factors and reprogramming modulators for reprogramming cells to cdc1 cells, compositions and methods thereof | |
| US20050266544A1 (en) | Methods and compositions for increasing viral vector production in packaging cell lines | |
| Georgiadis | Viral vector-mediated RNA interference in the retina | |
| Csonka | Generation of prototype human satellite DNA-based artificial chromosomes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20190114 |